Euro RSCG Life to handle all new diabetes, thrombosis comms for Sanofi-Aventis

Sanofi-Aventis appointed Euro RSCG Life to handle all communications programs for all new diabetes and thrombosis drugs while renewing the network’s global assignments on Lovenox/Clexane, Lantus and Apidra, which the Havas network has handled since 2004. The firm also named Euro RSCG C&O to handle corporate communications.
You must be a registered member of MMM to post a comment.
 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.